Immunome
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -762%. Total operating expenses were $122,820,000.
Profit Margin
| 2018 | 0 | -7.84M | |
|---|---|---|---|
| 2019 | 0 | -10.55M | |
| 2020 | 0 | -17.12M | |
| 2021 | 0 | -24.46M | |
| 2022 | 0 | -37.51M | |
| 2023 | 14.01M | -106.80M | -761.92% |
IMNM Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 14.01M | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 22.92M | 631K | 755K | 755K | 615K | 0 |
Gross profit | -8.90M | -631K | -755K | -755K | -615K | 0 |
Operating exp. | ||||||
Research and development | 80.80M | 23.27M | 14.11M | 7.48M | 8.82M | 6.87M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 122.82M | 36.90M | 25.20M | 12.26M | 10.34M | 7.74M |
Operating income | -109.53M | -36.90M | -25.20M | -12.26M | -10.34M | -7.74M |
Other income (expenses), net | 2.72M | 5K | 493K | -5.57M | -96K | -102K |
Income before tax | -106.80M | -36.89M | -24.71M | -17.83M | -10.44M | -7.84M |
Income tax expense | 0 | 617K | -242K | -717K | 106K | 39K |
Net income | -106.80M | -37.51M | -24.46M | -17.12M | -10.55M | -7.84M |
Earnings per share | ||||||
Basic EPS | -5.38 | -3.09 | -2.12 | -1.69 | -1.84 | -1.79 |
Diluted EPS | -5.38 | -3.09 | -2.12 | -1.69 | -1.84 | -1.79 |
| Data source | Data source | Data source | Data source |